IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

ABG Innovation Capital Partners III GP Ltd

Q1 2021 Holdings

Filed 2021-05-17 | 7 holdings | $203.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Atea Pharmaceuticals IncCOM04653R106$163.0K2,639,17880.1%
Pulmonx Corp(LUNG)COM745848101$38.1K833,33318.7%
Genocea Biosciences Inc(GNCAQ)COM NEW372427401$1.0K375,0000.5%
Synlogic IncCOM87166L100$737205,9060.4%
Aerpio Pharmaceuticals IncCOM00810B105$516400,0000.3%
Nabriva Therapeutics PLCSHSG63637113$7645,8490.0%
Idera Pharmaceuticals IncCOM PAR45168K405$7356,2500.0%